Artelo Biosciences Stock Fundamentals
Artelo Biosciences fundamentals help investors to digest information that contributes to Artelo Biosciences' financial success or failures. It also enables traders to predict the movement of Artelo Stock. The fundamental analysis module provides a way to measure Artelo Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Artelo Biosciences stock.
Artelo |
Artelo Biosciences Company EBITDA Analysis
Artelo Biosciences' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Artelo Biosciences EBITDA | (10.29 M) |
Most of Artelo Biosciences' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Artelo Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Artelo Biosciences reported earnings before interest,tax, depreciation and amortization of (10.29 Million). This is much lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is notably higher than that of the company.
Artelo Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Artelo Biosciences's current stock value. Our valuation model uses many indicators to compare Artelo Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Artelo Biosciences competition to find correlations between indicators driving Artelo Biosciences's intrinsic value. More Info.Artelo Biosciences is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Artelo Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Artelo EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Artelo Biosciences' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Artelo Biosciences could also be used in its relative valuation, which is a method of valuing Artelo Biosciences by comparing valuation metrics of similar companies.Artelo Biosciences is currently under evaluation in ebitda category among its peers.
Artelo Fundamentals
Return On Equity | -0.71 | |||
Return On Asset | -0.44 | |||
Shares Outstanding | 2.33 M | |||
Number Of Shares Shorted | 339 | |||
EBITDA | (10.29 M) | |||
Net Income | (10.08 M) | |||
Cash And Equivalents | 457.33 K | |||
Cash Per Share | 0.23 X | |||
Total Debt | 63 K | |||
Current Ratio | 0.41 X | |||
Book Value Per Share | (0.35) X | |||
Cash Flow From Operations | (8.01 M) | |||
Earnings Per Share | (1.43) X | |||
Beta | 1.25 | |||
Market Capitalization | 13.07 K | |||
Total Asset | 20.42 M | |||
Retained Earnings | (31.02 M) | |||
Working Capital | 9.69 M | |||
Net Asset | 20.42 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Artelo Stock
If you are still planning to invest in Artelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Artelo Biosciences' history and understand the potential risks before investing.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |